Although these structures represent low-abundance N-glycans in bladder cancer (<10% of total glycan content in our bladder samples, and therefore not quantified among the most abundant ions), they are notable for their high affinity to GNL, potentially due to exposed mannose residues, and a deeper investigation into their biological relevance and biosynthetic origins is needed. The gene discussed is RGN; the disease is urinary bladder cancer.